Literature DB >> 16925519

NMR-based quality control approach for the identification of false positives and false negatives in high throughput screening.

Claudio Dalvit1, Dannica Caronni, Nicola Mongelli, Marina Veronesi, Anna Vulpetti.   

Abstract

The quality of the data generated in a high throughput screening (HTS) run is fundamental for selecting bona fide inhibitors and for ensuring the capture of the full richness of inhibitors present in a chemical library. For this purpose a quality control filter based on three one dimensional (1D) proton NMR experiments is proposed. The approach called SPAM (Solubility, Purity and Aggregation of the Molecule) Filter requires the acquisition of a 1D reference spectrum, a WaterLOGSY spectrum and/or a selective longitudinal relaxation filter spectrum for the identified hits dissolved in aqueous solution and in the presence of a water soluble reference molecule. This palette of experiments permits the rapid characterization of the identity, purity, solubility and aggregation state of the active compound. This knowledge is crucial for deriving accurate IC(50) and K(1) values of the inhibitors, for identifying false negatives and for detecting promiscuous inhibitors. Only compounds that pass through the SPAM Filter can be considered as starting points for medicinal chemistry efforts directed toward lead optimization. Examples of this approach in the identification of false positives in a screening run against the enzyme thymidine phosphorylase (TP) and the rescue of a false negative in a screening run against the Ser/Thr kinase AKT1 are presented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16925519     DOI: 10.2174/157016306778108875

Source DB:  PubMed          Journal:  Curr Drug Discov Technol        ISSN: 1570-1638


  16 in total

1.  The generation of purinome-targeted libraries as a means to diversify ATP-mimetic chemical classes for lead finding.

Authors:  Eduard R Felder; Alessandra Badari; Teresa Disingrini; Sergio Mantegani; Christian Orrenius; Nilla Avanzi; Antonella Isacchi; Barbara Salom
Journal:  Mol Divers       Date:  2012-02-15       Impact factor: 2.943

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41.

Authors:  Shidong Chu; Guangyan Zhou; Miriam Gochin
Journal:  Org Biomol Chem       Date:  2017-06-07       Impact factor: 3.876

4.  Metal impurities cause false positives in high-throughput screening campaigns.

Authors:  Johannes C Hermann; Yingsi Chen; Charles Wartchow; John Menke; Lin Gao; Shelley K Gleason; Nancy-Ellen Haynes; Nathan Scott; Ann Petersen; Stephen Gabriel; Binh Vu; Kelly M George; Arjun Narayanan; Shirley H Li; Hong Qian; Nanda Beatini; Linghao Niu; Qing-Fen Gan
Journal:  ACS Med Chem Lett       Date:  2012-12-12       Impact factor: 4.345

Review 5.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

Review 6.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

7.  Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.

Authors:  Samantha N Muellers; Juliana A Gonzalez; Abinash Kaur; Vital Sapojnikov; Annie Laurie Benzie; Dean G Brown; David W Parkin; Brian J Stockman
Journal:  ACS Infect Dis       Date:  2019-02-01       Impact factor: 5.084

Review 8.  The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.

Authors:  Donna M Huryn; Amos B Smith
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

9.  Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.

Authors:  Wolfgang Jahnke
Journal:  J Biomol NMR       Date:  2007-08-15       Impact factor: 2.582

10.  Suppression of problematic compound oligomerization by cosolubilization of nondetergent sulfobetaines.

Authors:  Yumiko Mizukoshi; Koh Takeuchi; Misa Arutaki; Takeshi Takizawa; Hiroyuki Hanzawa; Hideo Takahashi; Ichio Shimada
Journal:  ChemMedChem       Date:  2015-03-11       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.